Rachel Haurwitz is a prominent scientist and entrepreneur known for her work in the field of biotechnology. She is a co-founder of Caribou Biosciences, a biopharmaceutical company that focuses on developing CRISPR-Cas9 gene-editing technology for therapeutic applications. Under her leadership, Caribou has been involved in pioneering research and development in genetic engineering and has contributed to advancements in gene therapy and other related fields.
Articles by others on the same topic
There are currently no matching articles.